Richard Parsons
Overview
Explore the profile of Richard Parsons including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
1178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lau J, Frydrych A, Parsons R, Balasubramaniam R, Kujan O
J Pers Med
. 2024 Dec;
14(12).
PMID: 39728060
This study evaluated the accuracy of diagnosing oral and maxillofacial diseases using telehealth. We recruited 100 patients from the Oral Health Centre of Western Australia. They were either new patients...
2.
Jules E, Decker C, Bixler B, Ahmed A, Zhou Z, Arora I, et al.
medRxiv
. 2024 Sep;
PMID: 39228743
Genomic epidemiology offers important insight into the transmission and evolution of respiratory viruses. We used metagenomic sequencing from negative SARS-CoV-2 antigen tests to identify a wide range of respiratory viruses...
3.
Azzopardi M, Parsons R, Cadby G, King S, McArdle N, Singh B, et al.
Chest
. 2024 Aug;
166(5):1197-1208.
PMID: 39134145
Background: Patients with OSA are at increased risk of postoperative cardiorespiratory complications and death. Attempts to stratify this risk have been inadequate, and predictors from large, well-characterized cohort studies are...
4.
McNabb L, Metrot E, Ferrington M, Sunderland B, Parsons R, Copeland T, et al.
PLoS One
. 2024 Jun;
19(6):e0304011.
PMID: 38870231
Background: Oral antineoplastic agents have caused a paradigm shift in cancer treatment, however, they produce many unique challenges. Although oral antineoplastics can have complex administration regimes, low adherence rates and...
5.
Bulonza R, Watkins K, Parsons R, Sunderland B, Whitehouse A, Caccetta R
Autism
. 2024 Feb;
28(8):2002-2013.
PMID: 38385262
Prescriptions and use of medications to treat mental health conditions in young autistic populations are inconsistent worldwide. This makes it hard to compare findings from international studies to the Australian...
6.
Frydrych A, Parsons R, Kujan O
Oral Dis
. 2023 Dec;
30(7):4165-4173.
PMID: 38105485
Objectives: Malnutrition is common among patients with head and neck cancer (HNC) and associated with poorer outcomes. Oral nutritional supplements (ONS) are often prescribed, with concerns raised about their cariogenicity....
7.
Rao A, Lin J, Parsons R, Greenleaf M, Westbrook A, Lai E, et al.
medRxiv
. 2023 Nov;
PMID: 37986832
Motivation: The motivation for this work was the need to establish a predefined cutoff based on genome copies per ml (GE/ml) rather than Ct, which can vary depending on the...
8.
Frediani J, Parsons R, McLendon K, Westbrook A, Lam W, Martin G, et al.
Clin Infect Dis
. 2023 Sep;
78(2):301-307.
PMID: 37768707
Background: Early in the coronavirus disease 2019 (COVID-19) pandemic, peak viral loads coincided with symptom onset. We hypothesized that in a highly immune population, symptom onset might occur earlier in...
9.
Rao A, Westbrook A, Bassit L, Parsons R, Fitts E, Greenleaf M, et al.
J Clin Microbiol
. 2023 Sep;
61(10):e0013823.
PMID: 37728336
Rapid antigen tests (RATs) have become an invaluable tool for combating the COVID-19 pandemic. However, concerns have been raised regarding the ability of existing RATs to effectively detect emerging SARS-CoV-2...
10.
Frediani J, Pak-Harvey E, Parsons R, Westbrook A, OSick W, Martin G, et al.
Blood Cells Mol Dis
. 2023 May;
102:102756.
PMID: 37257234
Prior literature has established a positive association between sickle cell disease and risk of contracting SARS-CoV-2. Data from a cross-sectional study evaluating COVID-19 testing devices (n = 10,567) was used...